Epstein Secrets

rts Human Vaccine Trials. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in

tdowns." Reuters <https://www.reuters.corrilarticle/us-usa-stocks/sp-dips-on-worries-about-eamings-data-stimulus-and-election- idUSKCN24V1Y7> (7/30, Carew) reports "the Dow Jones Industrial Average fell 225.92 points, or 0.85%, to 26,313.65, the S&P 500 lost 12.22 points, or 0.38%, to 3,246.22 and the

ted States to produce a rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in

nomic contraction in the second quarter as the coronavirus pandemic battered the economy, leading to widespread business shutdowns." Reuters (7/30, Carew) reports "the Dow Jones Industrial Average fell EFTA00150196 225.92 points, or 0.85%, to 26,313.65, the S&P 500 lost 12.22 points, or 0.38%, to 3,

ted States to produce a rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in

nomic contraction in the second quarter as the coronavirus pandemic battered the economy, leading to widespread business shutdowns." Reuters (7/30, Carew) reports "the Dow Jones Industrial Average fell 225.92 points, or 0.85%, to 26,313.65, the S&P 500 lost 12.22 points, or 0.38%, to 3,246.22 and the